Market Currents
More on Cepheid (CPHD): Q2 comes in-line on a per share basis but comes up shy on revenue...
-
Thursday, July 19, 2012, 4:52 PM ETMore on Cepheid (CPHD): Q2 comes in-line on a per share basis but comes up shy on revenue despite a 20% Y/Y jump in total sales. Looking forward into the second half however, the company says it's taking a more cautious view. For FY 2012, the company expects revenue in the range of $333M to $347M and an EPS of $0.38 to $0.42 per share. The Street is at $342M in revenue on earnings of $0.49 per share. Shares remain halted AH.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
